Dr. Edward Philbin, Medical director of the Heart Failure Program at Albany Medical Center told the Daily Gazette of Schenectady, New York that Aquapheresis is an innovative therapy that removes dangerous levels of excess fluid in patients suffering from congestive heart failure.
Congestive heart failure is the most expensive diagnosis in the medicare Program-over $30 Billion. The therapy has proven to be more effective in removing excess fluid than standard treatment and reduces the likelihood of repeated hospitalizations for congestive heart failure, said Philbin.
"The new research coming out and studies we are participating in would suggest that aquapheresis is more effective and safer than diuretics," he added. Aquapheresis is the first major advancement for acute fluid removal in the setting of acute heart failure since the introduction of diuretics more than 50 years ago.
Philbin explained that aquapheresis uses the process of ultrafiltration to remove excess sodium and water from the body. Blood is withdrawn through a catheter and circulated through the filter system that separates the fluids from the blood.
The Nevada Biotechnology & Bioscience meeting is Thursday, July 10, 2008 at Tommy Bahama's Tropical Cafe in Town Square at 6635 Las Vegas Blvd. The cost is $35.
RSVP with Judith at 702-839-7222 or jrebholz@cvbt.org.